Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)
NCT04965636
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypereosinophilic Syndrome
Interventions
DRUG:
Mepolizumab
Sponsor
GlaxoSmithKline